Summary
This 8-K filing from DexCom, Inc. (DXCM) on March 14, 2008, reports a significant internal promotion within its finance department. Effective immediately on March 13, 2008, Jess Roper was promoted to the position of Vice President and Chief Financial Officer (CFO). Mr. Roper has been with DexCom since March 2005, initially as Director of Finance, and has been serving as interim CFO since July 2007, indicating a smooth transition and internal recognition of his capabilities. This promotion is a key development for investors, signaling stability and continuity in financial leadership. Mr. Roper's background includes prior experience at SeraCare Life Sciences and Nanogen, as well as a CPA license and experience with PricewaterhouseCoopers, suggesting a strong foundation for his new role. The filing also notes an increase in his base salary to $200,000, with continued eligibility for incentive programs, aligning his compensation with his increased responsibilities.
Key Highlights
- 1DexCom, Inc. announced the promotion of Jess Roper to Vice President and Chief Financial Officer (CFO) effective March 13, 2008.
- 2Mr. Roper has been with DexCom since March 2005, previously holding roles including Director of Finance and interim CFO.
- 3His prior experience includes roles at SeraCare Life Sciences, Inc. and Nanogen, Inc.
- 4Mr. Roper is a licensed Certified Public Accountant (CPA) in California and has experience with PricewaterhouseCoopers, LLP.
- 5His base salary has been increased to $200,000 upon his promotion.
- 6He will remain eligible for the company's short-term and long-term incentive programs.
- 7There is no written employment agreement with Mr. Roper.